| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | Atlas Venture Fund XI, L.P. | - | Sell | 344,123 | $23.53 | $8,096,773.67 | -1.2% | → |
| 2024-02-16 | Rhodes Jason P | - | Sell | 340,613 | $23.53 | $8,014,639.67 | -1.6% | → |
| 2024-02-12 | Farwell Wildon | Chief Medical Officer | Sell | 5,493 | $25.07 | $137,709.51 | -3.3% | → |
| 2024-01-26 | Farwell Wildon | Chief Medical Officer | Sell | 100 | $25.00 | $2,500.00 | - | → |
| 2024-01-26 | McNeill Jonathan | Chief Business Officer | Sale+OE | 20,000 | $24.53 | $490,510.36 | -6.5% | → |
| 2024-01-26 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sale+OE | 13,000 | $24.34 | $316,420.00 | -9.5% | → |
| 2024-01-09 | Kersten Dirk | - | Buy | 1,714,285 | $17.50 | $29,999,987.50 | +28.0% | → |
| 2024-01-04 | Brumm Joshua T | CEO & President | Sale+OE | 269,719 | $18.66 | $5,032,915.18 | -8.2% | → |
| 2024-01-04 | Beskrovnaya Oxana | Chief Scientific Officer | Sale+OE | 87,779 | $18.57 | $1,629,985.42 | -10.8% | → |
| 2024-01-04 | McNeill Jonathan | Chief Business Officer | Sale+OE | 31,900 | $16.59 | $529,194.30 | -5.2% | → |
| 2024-01-03 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sale+OE | 13,000 | $18.81 | $244,530.00 | -9.5% | → |
| 2023-12-14 | Scalzo Richard William | See Remarks | Sell | 2,376 | $12.02 | $28,559.52 | -1.9% | → |
| 2023-12-12 | Farwell Wildon | Chief Medical Officer | Sell | 2,666 | $10.66 | $28,413.26 | -0.8% | → |
| 2023-12-11 | Scalzo Richard William | See Remarks | Sell | 1,380 | $10.72 | $14,793.60 | -1.1% | → |
| 2023-12-11 | McNeill Jonathan | Chief Business Officer | Sell | 1,245 | $10.72 | $13,346.40 | -0.8% | → |
| 2023-12-11 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 1,616 | $10.72 | $17,323.52 | -0.9% | → |
| 2023-12-11 | Brumm Joshua T | See Remarks | Sell | 7,585 | $10.72 | $81,311.20 | -1.3% | → |
| 2023-12-11 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,467 | $10.72 | $15,726.24 | -0.8% | → |
| 2023-12-06 | Scalzo Richard William | See Remarks | Sell | 2,553 | $12.01 | $30,661.53 | -1.0% | → |
| 2023-11-02 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 9,939 | $7.40 | $73,548.60 | -9.5% | → |
| 2023-09-18 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 2,672 | $9.41 | $25,143.52 | -2.5% | → |
| 2023-09-18 | Brumm Joshua T | See Remarks | Sell | 12,032 | $9.41 | $113,221.12 | -4.9% | → |
| 2023-09-18 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,436 | $9.41 | $13,512.76 | -1.7% | → |
| 2023-09-18 | Scalzo Richard William | See Remarks | Sell | 1,290 | $9.41 | $12,138.90 | -3.1% | → |
| 2023-09-18 | McNeill Jonathan | Chief Business Officer | Sell | 1,261 | $9.41 | $11,866.01 | -2.0% | → |
| 2023-09-12 | McNeill Jonathan | Chief Business Officer | Sell | 1,266 | $10.41 | $13,179.06 | -2.0% | → |
| 2023-09-12 | Farwell Wildon | Chief Medical Officer | Sell | 1,707 | $10.41 | $17,769.87 | -1.9% | → |
| 2023-09-12 | Scalzo Richard William | See Remarks | Sell | 1,397 | $10.41 | $14,542.77 | -3.2% | → |
| 2023-09-12 | HIGH SUSANNA GATTI | Chief Operating Officer | Sell | 1,635 | $10.41 | $17,020.35 | -1.5% | → |
| 2023-09-12 | Brumm Joshua T | See Remarks | Sell | 7,672 | $10.41 | $79,865.52 | -3.0% | → |
| 2023-09-12 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | 1,484 | $10.41 | $15,448.44 | -1.7% | → |